Abstract
Chimeric Antigen Receptor (CAR) therapy is a new approach that utilizes bioengineering to modify immune cells so they are able to specifically target and kill pathogens or altered host immune cells (such as cancers). This approach involves generating modified cell surface molecules (chimeric receptors) and expressing these receptors in host immune cells. As these chimeric receptors recogn…